DB
VMD icon

Dmitry Balyasny’s Viemed Healthcare VMD Stock Holding History

Dmitry Balyasny’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,861
Closed -$134K – 2833
2023
Q1 		$134K Sell
13,861
-7,382
-35% -$64.4K ﹤0.01% 2286
2022
Q4 		$161K Buy
+21,243
New +$144K ﹤0.01% 2174

Other funds holding VMD

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $4.39B AUM 72.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TPM
Triasima Portfolio Management Montreal, Quebec, Canada $740M AUM 69.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dmitry Balyasny's VMD Position: Q2 2023 in Review

Dmitry Balyasny sold out of Viemed Healthcare (VMD) in Q2 2023, closing a stake of 13,861 shares — an estimated $134K sold.

Dmitry Balyasny first reported a position in VMD in Q4 2022 and held it in 2 quarters. The position peaked at $161K in Q4 2022. 103 funds tracked by Wall St. Rank hold VMD as of Q2 2023.

  • Dmitry Balyasny reported no remaining Viemed Healthcare position as of Q2 2023 after selling out during the quarter.
  • Dmitry Balyasny sold 13,861 Viemed Healthcare shares in Q2 2023, an estimated $134K.
  • Dmitry Balyasny first reported a position in Viemed Healthcare in Q4 2022 and held it in 2 quarters.
  • Dmitry Balyasny's Viemed Healthcare position peaked at $161K in Q4 2022.
  • 103 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.